RecruitingNot applicableNCT05124808
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Sponsor: Indiana University
Indianapolis, IN · +4 more sites
Obesity clinical trials in Indianapolis, IN
18 recruiting obesity studies with a site in Indianapolis, IN.
RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Indianapolis, IN · +55 more sites
RecruitingPhase 2NCT07783802
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Sponsor: Eli Lilly and Company
Indianapolis, IN · +29 more sites
RecruitingPhase 3NCT06672549
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Sponsor: Eli Lilly and Company
Indianapolis, IN · +49 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
Indianapolis, IN · New Albany, IN · +35 more sites
RecruitingPhase 3NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Sponsor: Eli Lilly and Company
Indianapolis, IN · New Albany, IN · +33 more sites
RecruitingPhase 3NCT07253285
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Sponsor: Novo Nordisk A/S
Indianapolis, IN · +33 more sites
RecruitingPhase 3NCT07668414
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Sponsor: Novo Nordisk A/S
Indianapolis, IN · +44 more sites
RecruitingPhase 3NCT06439277
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Sponsor: Eli Lilly and Company
Indianapolis, IN · +13 more sites
RecruitingPhase 3NCT07339423
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Sponsor: Novo Nordisk A/S
Indianapolis, IN · +21 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Elkhart, IN · Indianapolis, IN · Munster, IN · +118 more sites
RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Evansville, IN · Indianapolis, IN · Valparaiso, IN · +81 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Indianapolis, IN · Plainfield, IN · +37 more sites
RecruitingPhase 3NCT07745504
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Sponsor: Novo Nordisk A/S
Indianapolis, IN · +10 more sites
RecruitingPhase 3NCT06366464
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Sponsor: Harmony Biosciences Management, Inc.
Indianapolis, IN · +22 more sites
Not yet recruitingPhase 3NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Indianapolis, IN · +54 more sites
Not yet recruitingPhase 3NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Sponsor: Eli Lilly and Company
Indianapolis, IN · +24 more sites
Not yet recruitingNot applicableNCT07856784
Cognitive and Behavioral Approaches to Reduce Binge Eating and Excess Weight in Adolescents (Online)
Sponsor: Indiana University
Indianapolis, IN
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.